Acadia Healthcare (NASDAQ:ACHC) Receives Neutral Rating from Cantor Fitzgerald

Cantor Fitzgerald reissued their neutral rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a $90.00 price target on the stock.

A number of other brokerages also recently weighed in on ACHC. Royal Bank of Canada reiterated an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Wednesday, May 22nd. StockNews.com lowered shares of Acadia Healthcare from a hold rating to a sell rating in a research note on Tuesday, May 21st. Bank of America dropped their price target on shares of Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a research note on Thursday, May 2nd. Barclays reduced their price objective on Acadia Healthcare from $91.00 to $89.00 and set an overweight rating for the company in a research report on Wednesday, May 15th. Finally, TheStreet raised Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Moderate Buy and a consensus price target of $87.56.

Acadia Healthcare Stock Down 1.3 %

ACHC stock opened at $66.12 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a market capitalization of $6.13 billion, a P/E ratio of -472.25, a P/E/G ratio of 2.03 and a beta of 1.31. Acadia Healthcare has a 52-week low of $62.04 and a 52-week high of $87.77. The company’s 50 day simple moving average is $68.28 and its 200-day simple moving average is $75.72.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. During the same period in the previous year, the business earned $0.75 EPS. The company’s revenue was up 9.1% on a year-over-year basis. As a group, equities research analysts anticipate that Acadia Healthcare will post 3.52 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after buying an additional 30,296 shares during the period. Wellington Management Group LLP boosted its holdings in Acadia Healthcare by 2.1% during the third quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock valued at $529,991,000 after acquiring an additional 152,783 shares during the period. Avidity Partners Management LP grew its position in shares of Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after purchasing an additional 441,692 shares during the last quarter. Jennison Associates LLC increased its stake in shares of Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock worth $89,327,000 after purchasing an additional 238,114 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in Acadia Healthcare by 3.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,035,114 shares of the company’s stock valued at $80,490,000 after purchasing an additional 38,410 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.